Tag: Motival

Nearly one-half of those diagnosed with depression are also diagnosed with an anxiety disorder. This high rate of co-occurrence has led to the development of combination therapies, but the question remains: **Is Motival in the treatment of anxiety with or without depression** a viable option?

In 2008, the pharmaceutical company Bristol-Myers Squibb announced that Motival (fluphenazine hydrochloride 500µg), a medication used for mixed anxiety and depression, would be discontinued globally for commercial reasons. This decision ended the availability of a fixed-dose combination drug, highlighting shifts in pharmaceutical treatment paradigms.

Psychiatric research shows that anxiety and depression often coexist in patients, a condition for which standard treatments may be insufficient. In these cases, a combination medication like Motival Tablet, containing both an antidepressant and an antipsychotic, can be prescribed to address the complex symptoms.